(Total Views: 293)
Posted On: 06/03/2022 1:05:51 PM
Post# of 116

$IONS News Article - Ionis partner Biogen announces that results from Phase 3 VALOR study and open-label extension of tofersen showed clinical benefit in SOD1-ALS patients https://marketwirenews.com/news-releases/ioni...53979.html


My Twitter: WhyteStocks